home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Intersect ENT, Inc. - Common Stock (NQ:XENT)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, May 12, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Intersect ENT, Inc. - Common Stock

Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization

January 25, 2022

From Intersect ENT, Inc.

Via Business Wire

Intersect ENT Reports Third Quarter 2021 Financial Results

November 02, 2021

From Intersect ENT, Inc.

Via Business Wire

First Implants of PROPEL® Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in Europe

October 28, 2021

From Intersect ENT®, Inc.

Via Business Wire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates INOV, LMRK, XENT, JAX; Shareholders are Encouraged to Contact the Firm

September 13, 2021

NEW YORK, NY / ACCESSWIRE / September 13, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Inovalon Holdings, Inc. (NASDAQ: INOV)...

From Halper Sadeh LLP

Via AccessWire

Topics Fraud

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates INOV, GTS, XONE, XENT; Shareholders are Encouraged to Contact the Firm

September 04, 2021

NEW YORK, NY / ACCESSWIRE / September 4, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Inovalon Holdings, Inc. (NASDAQ:INOV)...

From Halper Sadeh LLP

Via AccessWire

Topics Fraud

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CSOD, XENT, FFWM, RIVE; Shareholders are Encouraged to Contact the Firm

August 19, 2021

NEW YORK, NY / ACCESSWIRE / August 19, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Cornerstone OnDemand, Inc. (NASDAQ:CSOD)...

From Halper Sadeh LLP

Via AccessWire

Topics Fraud

INVESTIGATION: Halper Sadeh LLP Investigates NLOK, XENT, NWHM; Shareholders are Encouraged to Contact the Firm

August 12, 2021

NEW YORK, NY / ACCESSWIRE / August 12, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: NortonLifeLock Inc. (NASDAQ:NLOK) concerning...

From Halper Sadeh LLP

Via AccessWire

Topics Fraud

INTERSECT ENT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intersect ENT - XENT

August 06, 2021

From Kahn Swick & Foti, LLC

Via Business Wire

Intersect ENT Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Intersect ENT, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – XENT

August 06, 2021

From Halper Sadeh LLP

Via Business Wire

Intersect ENT Reports Second Quarter 2021 Financial Results

August 06, 2021

From Intersect ENT, Inc.

Via Business Wire

U.S Nationwide Commercial Availability of the VenSure™ Balloon Sinus Dilation System and Cube™ Navigation System Highlight Intersect ENT’s Continued Commitment to Providing Innovative, Solutions for Patients with Chronic Rhinosinusitis

July 26, 2021

From Intersect ENT

Via Business Wire

Intersect ENT to Report Second Quarter 2021 Financial Results on August 6

July 23, 2021

From Intersect ENT, Inc.

Via Business Wire

Intersect ENT Announces Preliminary Revenue for Second Quarter of 2021 and Closing of $60 Million Term Loan

July 22, 2021

From Intersect ENT, Inc.

Via Business Wire

Intersect ENT Receives CE Mark Approval for PROPEL® Contour for Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery

May 20, 2021

From Intersect ENT, Inc.

Via Business Wire

Intersect ENT Reports First Quarter 2021 Financial Results

May 10, 2021

From Intersect ENT, Inc.

Via Business Wire

Intersect ENT to Participate at Upcoming Investor Conferences

May 07, 2021

From Intersect ENT, Inc.

Via Business Wire

Intersect ENT Announces Appointment of New Vice President of Sales

May 04, 2021

From Intersect ENT, Inc.

Via Business Wire

Intersect ENT Announces Date Change for First Quarter 2021 Financial Results Announcement

April 29, 2021

From Intersect ENT, Inc.

Via Business Wire

EXPAND Post-Market Study Evaluating Longer-Term Outcomes of PROPEL® Contour Sinus Implant in the Frontal Sinus Ostia Following In-Office Balloon Sinus Dilation

April 29, 2021

From Intersect ENT, Inc.

Via Business Wire

Intersect ENT to Report First Quarter 2021 Financial Results

April 20, 2021

From Intersect ENT, Inc.

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com